Sixty-two kinds of drugs entered the centralized procurement. The tenth batch of centralized procurement was organized by the state, and the tenth batch of centralized procurement was opened in Shanghai on December 12, resulting in the result of quasi-selection. 62 kinds of drugs were successfully purchased, and 385 products from 234 enterprises were qualified for quasi-selection, involving hypertension, diabetes, tumors, cardiovascular and cerebrovascular diseases and other fields. The results of the proposed selection will be officially released after publicity. Since 2018, the National Medical Insurance Bureau has organized 10 batches of state-organized drug collection with relevant departments, and successfully purchased 435 kinds of drugs. (Xinhua News Agency)The concept of cryptocurrency in US stocks strengthened collectively at the beginning of the session, with Hut 8 and Riot Platforms rising by more than 8%, Bitdeer rising by more than 6%, TeraWulf and CleanSpark rising by more than 3%. In the news, US President-elect Trump announced that he would do some great things in the field of cryptocurrency.Novo Nordisk: After the clinical trial results of kidney therapy were released, European regulators gave Ozempic a positive label evaluation.
Trump: If Kennedy Jr. takes action, he will have a "big discussion" on ending the children's vaccination program.Guangxi Securities Regulatory Bureau issued a warning letter to Xinxunda and relevant responsible persons. According to the website of the CSRC, Guangxi Securities Regulatory Bureau issued a decision on taking measures to issue a warning letter to Guangxi Xinxunda Technology Group Co., Ltd. and relevant responsible persons. Among them, it is mentioned that Xinxunda has some problems, such as the occupation of non-operating funds of related parties and the failure to disclose them in time, the failure to review and disclose the external financial assistance in time, and the irregular management of insider registration. The Guangxi Securities Regulatory Bureau decided to issue warning letters to Xinxunda, Wu Chenghua, Wang Fabin, Yan Ming, Chen Gong, Li Yangang and Ye Yanzhen.Novo Nordisk: After the clinical trial results of kidney therapy were released, European regulators gave Ozempic a positive label evaluation.
European Central Bank President Lagarde: Labor cost growth will slow down.Syrian Information Minister: Turkish Foreign Minister, Intelligence Minister and Qatar National Security Minister met with Syrian opposition leader Shara and caretaker Prime Minister Bashir in Damascus.European Central Bank President Lagarde: National elections have also led to their own uncertainties.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14